申请人:Nilsson Peter
公开号:US20120004244A1
公开(公告)日:2012-01-05
There is provided compounds of formula I,
wherein E
1
, E
2a
, E
2b
, E
2c
, E
4
, D
1
, D
2
, D
3
, L
1
, Y
1
, L
2
and Y
2
have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of leukotriene C
4
synthase is desired and/or required, and particularly in the treatment of a respiratory disorder and/or inflammation.
提供了I式化合物,其中E1、E2a、E2b、E2c、E4、D1、D2、D3、L1、Y1、L2和Y2在说明中给出了含义,以及其药学上可接受的盐。这些化合物在治疗需要或希望抑制白三烯C4合酶的疾病,特别是呼吸道疾病和/或炎症的治疗中是有用的。